Guided Therapeutics's market cap is currently $7.82M. The company's EPS TTM is $-0.042; its P/E ratio is ―; Guided Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 98.00K	$ 13.00K	$ 81.00K	$ 102.00K	$ 36.00K
Gross Profit	$ 36.00K	$ -68.00K	$ 20.00K	$ 61.00K	$ -34.00K
Operating Income	$ -3.46M	$ -3.33M	$ -2.36M	$ -1.05M	$ -937.00K
EBITDA	$ -3.13M	$ -3.69M	$ -919.00K	$ 777.00K	$ -488.00K
Net Income	$ -3.49M	$ -4.97M	$ -3.73M	$ -1.33M	$ -3.38M
Balance Sheet
Cash & Short-Term Investments	$ 591.00K	$ 2.31M	$ 643.00K	$ 182.00K	$ 899.00K
Total Assets	$ 1.67M	$ 3.37M	$ 2.04M	$ 1.35M	$ 1.18M
Total Debt	$ 2.06M	$ 2.26M	$ 2.90M	$ 4.41M	$ 6.02M
Net Debt	$ 1.47M	$ -50.00K	$ 2.26M	$ 4.22M	$ 5.12M
Total Liabilities	$ 5.47M	$ 6.25M	$ 7.49M	$ 12.21M	$ 18.11M
Stockholders' Equity	$ -3.81M	$ -2.88M	$ -5.45M	$ -10.86M	$ -16.93M
Cash Flow
Free Cash Flow	$ -1.75M	$ -1.51M	$ -1.61M	$ -1.88M	$ -806.00K
Operating Cash Flow	$ -1.75M	$ -1.48M	$ -1.59M	$ -1.88M	$ -806.00K
Investing Cash Flow	$ 0.00	$ -31.00K	$ -14.00K	$ -1.00K	$ 0.00
Financing Cash Flow	$ 24.00K	$ 3.18M	$ 2.07M	$ 1.16M	$ 1.71M

Currency in USD

Guided Therapeutics Earnings and Revenue History

Income Statement >

Guided Therapeutics Debt to Assets

Balance Sheet >

Guided Therapeutics Cash Flow

Cash Flow >

Guided Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing